Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2019.1.52

Karalkova N.K.1, Pristupa V.V.1, Katulskaya T.V.2
Tear replacement therapy in patients after phacoemulsification of cataracts
1Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
2Vitebsk Regional Clinical Hospital, Vitebsk, Republic of Belarus

Vestnik VGMU. 2019;18(1):52-58.

Abstract.
The research was performed at the department of eye microsurgery in the Vitebsk Regional Clinical Hospital. The article presents data of dynamic observation of changes in corneal thickness in 50 patients after performing cataract ultrasound phacoemulsification with the implantation of a soft intraocular lens during the first 5 days of the postoperative period with standard anti-inflammatory treatment and additional use of the drug based on cationic nanoemulsion as tear replacement therapy. Patients, with diabetes mellitus, diseases of the joints and connective tissue, glaucoma, inflammatory diseases of the choroid and refractive operations in their case history, were excluded from the research. Patients with corneal thickness less than 900 microns were included in it. It has been established that the use of cationic nanoemulsion containing glycerin in the early postoperative period accelerates the restoration of the normal thickness of the cornea, improves visual functions, reduces the rehabilitation term of patients after surgery. The drug possesses some properties of keratoprotector and osmocorrector, which enables recommendation of it for use beginning with the first days of the postoperative period after performing cataract phacoemulsification with the implantation of an intraocular lens in patients with corneal edema, that does not exceed 900 microns in thickness.
The article also lists the drugs of the “artificial tear” group, available for clinical use in the Republic of Belarus, with the indication of their active base, additional active ingredients, the presence or absence of a preservative, the possibility of applying directly to a contact lens.
Key words: tear replacement therapy, cationic nanoemulsion, cataract phacoemulsification, postoperative period.

References

1. Astakhov SYu, Tkachenko NV. Detection and treatment of dry eye syndrome in patients who have undergone phacoemulsification. Oftal’mol Ved. 2011;4(4):79-83. (In Russ.)
2. Уражанова МБ. Синдром «сухого глаза» в артифакичных глазах (обзор). Вестн АГИУВ Urazhanova MB. Dry Eye Syndrome in Artifacial Eyes (overview). Vestn AGIUV. 2018;(2):6-12. (In Russ.)
3. Brzheskiy VV, Egorova GB, Egorov EA. Dry Eye Syndrome and Eye Surface Diseases: Clinic, Diagnostics, Treatment. Moscow, RF: GEOTAR-Media; 2016. 464 р. (In Russ.)
4. Khanal S, Tomlinson A, Esakowitz L, Bhatt P, Jones D, Nabili S, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt. 2008 Mar;28(2):127-34. doi: http://dx.doi.org/10.1111/j.1475-1313.2008.00539.x
5. Sahu PK, Das GK, Malik A, Biakthangi L. Dry Eye Following Phacoemulsification Surgery and its Relation to Associated Intraoperative Risk Factors. Middle East Afr J Ophthalmol. 2015 Oct-Dec;22(4):472-7. doi: http://dx.doi.org/10.4103/0974-9233.151871
6. Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007 Oct;26(9 Suppl 1):S16-20.
7. Brzheskiy VV. Algorithm for selection of tear replacement therapy in patients in outpatient practice. RMZh. Klin Oftal’mologiia. 2018;(1):13-9. (In Russ.)
8. Eremenko AI, Boyko AA, Yanchenko SV, Dubinkina VO, Kulikova OV. Prevention of combined dry eye syndrome in elderly patients after cataract surgery. RMZh Klin Oftal’mologiia. 2006;7(3):122-5. (In Russ.)
9. Behrens A, Stark WJ, Pratzer KA, McDonnell PJ. Dynamics of small-incision clear cornea wounds after phacoemulsification surgery using optical coherence tomography in the early postoperative period. J Refract Surg. 2008 Jan;24(1):46-9. doi: http://dx.doi.org/10.3928/1081597X-20080101-07
10. Morkhat MV, Katul’skaya TV, Morkhat EV. Effect of Ocutiarz on corneal thickness dynamics in the postoperative period of uncomplicated cataract phacoemulsification. Oftal’mologiia Vostoch Evropa. 2015;(4):142-8. (In Russ.)
11. Shul’pina NB, Alieva ZA, Borishpolets VN, Gasilina VM, Gontuar NS. Therapeutic ophthalmology. Moscow, RF: Meditsina; 1985. 559 р. (In Russ.)
12. Xue W, Zhu MM, Zhu BJ, Huang JN, Sun Q, Miao YY, et al. Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. Int Ophthalmol. 2018 Feb. Available from: https://link.springer.com/article/10.1007%2Fs10792-018-0828-z [Accessed 19th Dec 2018].
13. Vokhmyakov AV. Evolution of tear substitutes: from saline solutions to cationic nanoemulsion. Oftal’mol Vedomosti. 2014;7(1):41-6. (In Russ.)
14. Teping Ch. Hyaluronsäure: Behandlung des Sicca-Syndroms; wirksam und verträglich auch mit Kontaktlinsen. In: Thieme drug report. Stuttgart; New York: Thieme; 2010.
15. Daull P, Lallemand F, Garrigue JS. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery / P. Daull, F. Lallemand, J. S. Garrigue. J Pharm Pharmacol. 2014 Apr;66(4):531-41. doi: http://dx.doi.org/10.1111/jphp.12075
16. Robert PY, Cochener B, Amrane M, Ismail D, Garrigue JS, Pisella PJ, et al. Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Eur J Ophthalmol. 2016 Nov;26(6):546-555. doi: http://dx.doi.org/10.5301/ejo.5000830
17. Amrane M, Creuzot-Garcher C, Robert PY, Ismail D, Garrigue JS, Pisella PJ, et al. Ocular tolerability and efficacy of a cationic emulsion in patients with midl to moderate dry eye disease – a randomised comparative study. J Fr Ophtalmol. 2014 Oct;37(8):589-98. doi: http://dx.doi.org/10.1016/j.jfo.2014.05.001

Information about authors:
Karalkova N.K. – Candidate of Medical Sciences, associate professor, acting head of the Chair of Ophthalmology, Vitebsk State Order of Peoples’ Friendship Medical University,
ORCID: https://orcid.org/0000-0002-6172-6767;
Pristupa V.V. – Candidate of Medical Sciences, associate professor of the Chair of Ophthalmology, Vitebsk State Order of Peoples’ Friendship Medical University;
Katulskaya T.V. – ophthalmologist, head of the department of eye microsurgery, Vitebsk Regional Clinical Hospital.

Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Ophthalmology. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Natallia K. Karalkova.

Поиск по сайту